Contribution of proteomics to the study of the role of cytokeratins in disease and physiopathology

Proteomics - Clinical Applications

Volumn 2, Issue 2, 2008, Pages 264-285

  Brouillard, Franck ^a,b   Fritsch, Janine ^a,b   Edelman, Aleksander ^a,b   Ollero, Mario ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Biomarkers; Interactomics; Intermediate filaments; Keratin

Indexed keywords

BIOLOGICAL MARKER; CISPLATIN; CYTOKERATIN; CYTOKERATIN 1; CYTOKERATIN 10; CYTOKERATIN 13; CYTOKERATIN 14; CYTOKERATIN 16; CYTOKERATIN 17; CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 20; CYTOKERATIN 4; CYTOKERATIN 8; CYTOSKELETON PROTEIN; DOXORUBICIN; ETOPOSIDE; INTERMEDIATE FILAMENT PROTEIN; MITOXANTRONE; PACLITAXEL; PRODIGIOSIN; RETINOIC ACID; TRANSMEMBRANE CONDUCTANCE REGULATOR; VINCRISTINE;

APOPTOSIS; BACTERIAL INFECTION; BIOTECHNOLOGY; BREAST CANCER; CANCER INHIBITION; CARCINOGENESIS; CELL DIFFERENTIATION; CHRONIC FATIGUE SYNDROME; COLORECTAL CANCER; CYSTIC FIBROSIS; DIGESTIVE SYSTEM CANCER; EMBRYO DEVELOPMENT; EYE DISEASE; HEPATITIS; HUMAN; INFLAMMATION; KERATOCONUS; LIVER CANCER; LIVER DISEASE; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MOLECULAR MECHANICS; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARY CARCINOMA; PATHOPHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEOMICS; REVIEW; STOMACH CANCER; THYROID CANCER; TISSUE REPAIR; TWO DIMENSIONAL ELECTROPHORESIS; UROGENITAL TRACT CANCER; VIRUS INFECTION; VITREORETINOPATHY;

BACTERIA (MICROORGANISMS);

EID: 39649089387     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200780018     Document Type: Review

References (180)

1. Plowman, J. E., The proteomics of keratin proteins. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2007, 849, 181-189.
2. Yoon, K. H., Yoon, M., Moir, R. D., Khuon, S. et al., Insights into the dynamic properties of keratin intermediate filaments in living epithelial cells. J. Cell. Biol. 2001, 153, 503-516.
3. Hesse, M., Magin, T. M., Weber, K., Genes for intermediate filament proteins and the draft sequence of the human genome: Novel keratin genes and a surprisingly high number of pseudogenes related to keratin genes 8 and 18. J. Cell Sci. 2001, 114, 2569-2575.
4. Schweizer, J., Bowden, P. E., Coulombe, P. A., Langbein, L. et al., New consensus nomenclature for mammalian keratins. J. Cell Biol. 2006, 174, 169-174.
5. Powell, B. C., Rogers, G. E., Formation and Structure of Human Hair, Birkauser Verlag, Basel 1997.
6. Zatloukal, K., Stumptner, C., Fuchsbichler, A., Fickert, P. et al., The keratin cytoskeleton in liver diseases. J. Pathol. 2004, 204, 367-376.
7. Toivola, D. M., Tao, G. Z., Habtezion, A., Liao, J., Omary, M. B., Cellular integrity plus: Organelle-related and protein-targeting functions of intermediate filaments. Trends Cell Biol. 2005, 15, 608-617.
8. Magin, T. M., Vijayaraj, P., Leube, R. E., Structural and regulatory functions of keratins. Exp. Cell Res. 2007, 313, 2021-2032.
9. Ku, N. O., Omary, M. B., Michie, S., Resurreccion, E. Z. et al., A disease- and phosphorylation-related nonmechanical function for keratin 8. J. Cell Biol. 2006, 174, 115-125.
10. Ku, N. O., Liao, J., Omary, M. B., Phosphorylation of human keratin 18 serine 33 regulates binding to 14-3-3 proteins. EMBO J. 1998, 17, 1892-1906.
11. Ku, N. O., Michie, S., Resurreccion, E. Z., Broome, R. L., Omary, M. B., Keratin binding to 14-3-3 proteins modulates keratin filaments and hepatocyte mitotic progression. Proc. Natl. Acad. Sci. USA 2002, 99, 4373-4378.
12. Hesse, M., Grund, C., Herrmann, H., Brohl, D. et al., A mutation of keratin 18 within the coil 1A consensus motif causes widespread keratin aggregation but cell type-restricted lethality in mice. Exp. Cell Res. 2007, 313, 3127-3140.
13. Tao, G. Z., Toivola, D. M., Zhou, Q., Strnad, P. et al., Protein phosphatase-2A associates with and dephosphorylates keratin 8 after hyposmotic stress in a site- and cell-specific manner. J. Cell Sci. 2006, 119, 1425-1432.
14. Loranger, A., Gilbert, S., Brouard, J. S., Magin, T. M., Marceau, N., Keratin 8 modulation of desmoplakin deposition at desmosomes in hepatocytes. Exp. Cell Res. 2006, 312, 4108-4119.
15. Long, H. A., Boczonadi, V., McInroy, L., Goldberg, M., Maatta, A., Periplakin-dependent re-organisation of keratin cytoskeleton and loss of collective migration in keratin-8-downregulated epithelial sheets. J. Cell Sci. 2006, 119, 5147-5159.
16. Toivola, D. M., Nieminen, M. I., Hesse, M., He, T. et al., Disturbances in hepatic cell-cycle regulation in mice with assembly-deficient keratins 8/18. Hepatology 2001, 34, 1174-1183.
17. Izawa, I., Inagaki, M., Regulatory mechanisms and functions of intermediate filaments: A study using site- and phosphorylation state-specific antibodies. Cancer Sci. 2006, 97, 167-174.
18. Margolis, S. S., Perry, J. A., Forester, C. M., Nutt, L. K. et al., Role for the PP2A/B56delta phosphatase in regulating 14-3-3 release from Cdc25 to control mitosis. Cell 2006, 127, 759-773.
19. Caulin, C., Ware, C. F., Magin, T. M., Oshima, R. G., Keratin-dependent, epithelial resistance to tumor necrosis factor-induced apoptosis. J. Cell Biol. 2000, 149, 17-22.
20. Jaquemar, D., Kupriyanov, S., Wankell, M., Avis, J. et al., Keratin 8 protection of placental barrier function. J. Cell Biol. 2003, 161, 749-756.
21. Inada, H., Izawa, I., Nishizawa, M., Fujita, E. et al., Keratin attenuates tumor necrosis factor-induced cytotoxicity through association with TRADD, J. Cell Biol. 2001, 155, 415-426.
22. Tong, X., Coulombe, P. A., Keratin 17 modulates hair follicle cycling in a TNFalpha-dependent fashion. Genes Dev. 2006, 20, 1353-1364.
23. Gilbert, S., Loranger, A., Marceau, N., Keratins modulate c-Flip/ extracellular signal-regulated kinase 1 and 2 anti-apoptotic signaling in simple epithelial cells. Mol. Cell. Biol. 2004, 24, 7072-7081.
24. Ku, N. O., Soetikno, R. M., Omary, M. B., Keratin mutation in transgenic mice predisposes to Fas but not TNF-induced apoptosis and massive liver injury. Hepatology 2003, 37, 1006-1014.
25. Ameen, N. A., Figueroa, Y., Salas, P. J., Anomalous apical plasma membrane phenotype in CK8-deficient mice indicates a novel role for intermediate filaments in the polarization of simple epithelia. J. Cell Sci. 2001, 114, 563-575.
26. Toivola, D. M., Krishnan, S., Binder, H. J., Singh, S. K., Omary, M. B., Keratins modulate colonocyte electrolyte transport via protein mistargeting. J. Cell Biol. 2004, 164, 911-921.
27. Satoh, M. I., Hovington, H., Cadrin, M., Reduction of cytochemical ecto-ATPase activities in keratin 8-deficient FVB/N mouse livers. Med. Electron. Microsc. 1999, 32, 209-212.
28. Gilbert, S., Loranger, A., Daigle, N., Marceau, N., Simple epithelium keratins 8 and 18 provide resistance to Fasmediated apoptosis. The protection occurs through a receptor-targeting modulation. J. Cell Biol. 2001, 154, 763-773.
29. Salas, P. J., Rodriguez, M. L., Viciana, A. L., Vega-Salas, D. E., Hauri, H. P. The apical submembrane cytoskeleton participates in the organization of the apical pole in epithelial cells. J. Cell Biol. 1997, 137, 359-375.
30. Hanada, S., Harada, M., Kumemura, H., Omary, M. B. et al., Keratin-containing inclusions affect cell morphology and distribution of cytosolic cellular components. Exp. Cell Res. 2005, 304, 471-482.
31. Habtezion, A., Toivola, D. M., Butcher, E. C., Omary, M. B., Keratin-8-deficient mice develop chronic spontaneous Th2 colitis amenable to antibiotic treatment. J. Cell Sci. 2005, 118, 1971-1980.
32. Franke, W. W., Schiller, D. L., Moll, R., Winter, S. et al., Diversity of cytokeratins. Differentiation specific expression of cytokeratin polypeptides in epithelial cells and tissues. J. Mol. Biol. 1981, 153, 933-959.
33. Moll, R., Franke, W. W., Volc-Platzer, B., Krepler, R., Different keratin polypeptides in epidermis and other epithelia of human skin: A specific cytokeratin of molecular weight 46,000 in epithelia of the pilosebaceous tract and basal cell epitheliomas. J. Cell Biol. 1982, 95, 285-295.
34. Blobel, G. A., Moll, R., Franke, W. W., Vogt-Moykopf, I., Cytokeratins in normal lung and lung carcinomas. I. Adenocarcinomas, squamous cell carcinomas and cultured cell lines. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 1984, 45, 407-429.
35. Gilmartin, M. E., Mitchell, J., Vidrich, A., Freedberg, I. M., Dual regulation of intermediate filament phosphorylation. J. Cell Biol. 1984, 98, 1144-1149.
36. Gilmartin, M. E., Culbertson, V. B., Freedberg, I. M., Phosphorylation of epidermal keratins. J. Invest. Dermatol. 1980, 75, 211-216.
37. Steinert, P. M., The dynamic phosphorylation of the human intermediate filament keratin 1 chain. J. Biol. Chem. 1988, 263, 13333-13339.
38. Ku, N. O., Omary, M. B., Expression, glycosyiation, and phosphorylation of human keratins 8 and 18 in insect cells. Exp. Cell Res, 1994, 211, 24-35.
39. Ku, N. O., Omary, M. B., Phosphorylation of human keratin 8 in vivo at conserved head domain serine 23 and at epidermal growth factor-stimulated tail domain serine 431. J. Biol. Chem. 1997, 272, 7556-7564.
40. Larsen, M. R., Sorensen, G. L., Fey, S. J., Larsen, P. M., Roepstorf, P., Phospho-proteomics: Evaluation of the use of enzymatic de-phosphorylation and differential mass spectrometric peptide mass mapping for site specific phosphorylation assignment in proteins separated by gel electrophoresis. Proteomics 2001, 1, 223-238.
41. Friedman, D. B., Hill, S., Keller, J. W., Merchant, N. S. et al., Proteome analysis of human colon cancer by two-dimensional difference gel electrophoresis and mass spectrometry. Proteomics 2004, 4, 793-811.
42. Ku, N. O., Darling, J. M., Krams, S. M., Esquivel, C. O. et al., Keratin 8 and 18 mutations are risk factors for developing liver disease of multiple etiologies. Proc. Natl. Acad. Sci. USA 2003, 100, 6063-6068.
43. Owens, D. W., Wilson, N. J., Hill, A. J., Rugg, E. L. et al., Human keratin 8 mutations that disturb filament assembly observed in inflammatory bowel disease patients. J. Cell Sci. 2004, 117, 1989-1999.
44. Cavestro, G. M., Frulloni, L., Nouvenne, A., Neri, T. M. et al., Association of keratin 8 gene mutation with chronic pancreatitis. Dig. Liver Dis. 2003, 35, 415-420.
45. Cleator, S., Heller, W., Coombes, R. C., Triple-negative breast cancer: Therapeutic options. Lancet Oncol. 2007, 8, 235-244.
46. Toth, T., Cytokeratins 7 and 14 in special types of invasive breast carcinomas. Med. Pregl. 1999, 52, 227-232.
47. Abe, T., Fukumoto, M., Tsuchiya, K., Kuramochi, K. et al., Human monoclonal antibodies against cytokeratin 18 generated from patients with gastric cancer. Jpn J. Cancer Res. 1989, 80, 271-276.
48. Dobashi, N., Fujita, J., Ohtsuki, Y., Yamadori, I. et al., Circulating cytokeratin 8:anti-cytokeratin 8 antibody immune complexes in sera of patients with pulmonary fibrosis. Respiration 2000, 67, 397-401.
49. Wang, N. P., Zee, S., Zarbo, R. J., Bacchi, C. E., Gown, A. M., Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Appl. Immunohistochem. 1995, 3, 99-107.
50. Stieber, P., Zimmermann, A., Reinmiedl, J., Muller, C. et al., CYFRA 21-1 in the early diagnosis of recurrent disease in non small cell lung carcinomas (NSCLC). Anticancer Res. 1999, 19, 2665-2668.
51. Yang, S. Y., Xiao, X. Y., Zhang, W. G., Zhang, L. J. et al., Application of serum SELDI proteomic patterns in diagnosis of lung cancer. BMC Cancer 2005, 5, 83.
52. He, P., Naka, T., Serada, S., Fujimoto, M. et al., Proteomics-based identification of alpha-enolase as a tumor antigen in non-small lung cancer. Cancer Sci. 2007, 98, 1234-1240.
53. Liu, Y., Chen, Q., Zhang, J. T., Tumor suppressor gene 14-3-3sigma is down-regulated whereas the proto-oncogene translation elongation factor 1delta is up-regulated in non-small cell lung cancers as identified by proteomic profiling. J. Proteome Res. 2004, 3, 728-735.
54. Cho, N. H., Koh, E. S., Lee, D. W., Kim, H. et al., Comparative proteomics of pulmonary tumors with neuroendocrine differentiation. J. Proteome Res. 2006, 5, 643-650.
55. Jin, L. J., Shin, B. K., Jung, W. Y., Lee, H. J. et al., Proteomic analysis of pulmonary sclerosing hemangioma. Proteomics 2006, 6, 4877-4883.
56. Gharib, T. G., Chen, G., Wang, H., Huang, C. C. et al., Proteomic analysis of cytokeratin isoforms uncovers association with survival in lung adenocarcinoma. Neoplasia 2002, 4, 440-448.
57. Gires, O., Munz, M., Schaffrik, M., Kieu, C. et al., Profile identification of disease-associated humoral antigens using AMIDA, a novel proteomics-based technology. Cell Mol. Life Sci. 2004, 61, 1198-1207,
58. Gires, O., Mack, B., Rauch, J., Matthias, C., CK8 correlates with malignancy in leukoplakia and carcinomas of the head and neck. Biochem. Biophys. Res. Commun. 2006, 343, 252-259.
59. Baker, H., Patel, V., Molinolo, A. A., Shillitoe, E. J. et al., Proteome-wide analysis of head and neck squamous cell carcinomas using laser-capture microdissection and tandem mass spectrometry. Oral Oncol. 2006, 41, 183-199.
60. Jazii, F. R., Najafi, Z., Malekzadeh, R., Conrads, T. P. et al., Identification of squamous cell carcinoma associated proteins by proteomics and loss of beta tropomyosin expression in esophageal cancer. World J. Gastroenterol. 2006, 12, 7104-7112.
61. Emmert-Buck, M. R., Gillespie, J. W., Paweletz, C. P., Ornstein, D. K. et al., An approach to proteomic analysis of human tumors. Mol. Carcinog. 2000, 27, 158-165.
62. Kinjo, T., Kamiyama, K., Chinen, K., Iwamasa, T. et al., Squamous metaplasia induced by transfection of human papillomavirus DNA into cultured adenocarcinoma cells. Mol. Pathol. 2003, 56, 97-108.
63. Nishikawa, J., Kiss, C., Imai, S., Takada, K. et al., Upregulation of the truncated basic hair keratin 1(hHb1-DeltaN) in carcinoma cells by Epstein-Barr virus (EBV). Int. J. Cancer 2003, 107, 597-602.
64. Yamamoto, K., Oka, M., Hayashi, H., Tangoku, A. et al., CYFRA 21-1 is a useful marker for esophageal squamous cell carcinoma. Cancer 1997, 79, 1647-1655.
65. Chung, J. Y., Braunschweig, T., Hu, N., Roth, M. et al., A multiplex tissue immunoblotting assay for proteomic profiling: A pilot study of the normal to tumor transition of esophageal squamous cell carcinoma. Cancer Epidemiol. Biomarkers Prev. 2006, 15, 1403-1408.
66. He, Q. Y., Cheung, Y. H., Leung, S. Y., Yuen, S. T. et al., Diverse proteomic alterations in gastric adenocarcinoma. Proteomics 2004, 4, 3276-3287.
67. Ormsby, A. H., Goldblum, J. R., Rice, T. W., Richter, J. E., Gramlich, T. L., The utility of cytokeratin subsets in distinguishing Barrett's-related oesophageal adenocarcinoma from gastric adenocarcinoma. Histopathology 2001, 38, 307-311.
68. Taniere, P., Borghi-Scoazec, G., Saurin, J. C., Lombard-Bohas, C. et al., Cytokeratin expression in adenocarcinomas of the esophagogastric junction: A comparative study of adenocarcinomas of the distal esophagus and of the proximal stomach. Am. J. Surg. Pathol. 2002, 26, 1213-1221.
69. Tot, T., Cytokeratins 20 and 7 as biomarkers: Usefulness in discriminating primary from metastatic adenocarcinoma. Eur. J. Cancer 2002, 38, 758-763.
70. Wauters, C. C., Smedts, F., Gerrits, L. G., Bosman, F. T., Ramaekers, F. C., Keratins 7 and 20 as diagnostic markers of carcinomas metastatic to the ovary. Hum. Pathol. 1995, 26, 852-855.
71. Herzig, K. H., Altmannsberger, M., Folsch, U. R., Intermediate filaments in rat pancreatic acinar tumors, human ductal carcinomas, and other gastrointestinal malignancies. Gastroenterology 1994, 106, 1326-1332.
72. Alfonso, P., Nunez, A., Madoz-Gurpide, J., Lombardia, L. et al., Proteomic expression analysis of colorectal cancer by two-dimensional differential gel electrophoresis. Proteomics 2005, 5, 2602-2611.
73. Polley, A. C., Mulholland, F., Pin, C., Williams, E. A. et al., Proteomic analysis reveals field-wide changes in protein expression in the morphologically normal mucosa of patients with colorectal neoplasia. Cancer Res. 2006, 66, 6553-6562.
74. Mouat, M. F., Kolli, K., Orlando, R., Hargrove, J. L., Grider, A., The effects of quercetin on SW480 human colon carcinoma cells: A proteomic study. Nutr J. 2005, 4, 11.
75. Poland, J., Sinha, P., Siegert, A., Schnolzer, M. et al., Comparison of protein expression profiles between monolayer and spheroid cell culture of HT-29 cells revealed fragmentation of CK18 in three-dimensional cell culture, Electrophoresis 2002, 23, 1174-1184.
76. Allal, A. S., Kahne, T., Reverdin, A. K., Lippert, H. et al., Radioresistance-related proteins in rectal cancer. Proteomics 2004, 4, 2261-2269.
77. Srisomsap, C., Sawangareetrakul, P., Subhasitanont, P., Panichakul, T. et al., Proteomic analysis of cholangiocarcinoma cell line. Proteomics 2004, 4, 1135-1144.
78. Le Naour, F., Brichory, F., Misek, D. E., Brechot, C. et al., A distinct repertoire of autoantibodies in hepatocellular carcinoma identified by proteomic analysis. Mol. Cell. Proteomics 2002, 1, 197-203.
79. Giometti, C. S., Tollaksen, S. L., Chubb, C., Williams, C., Huberman, E., Analysis of proteins from human breast epithelial cells using two-dimensional gel electrophoresis. Electrophoresis 1995, 16, 1215-1224.
80. Trask, D. K., Band, V., Zajchowski, D. A., Yaswen, P. et al., Keratins as markers that distinguish normal and tumor-derived mammary epithelial cells. Proc. Natl. Acad. Sci. USA 1990, 87, 2319-2323.
81. Roberts, K., Bhatia, K., Stanton, P., Lord, R., Proteomic analysis of selected prognostic factors of breast cancer. Proteomics 2004, 4, 784-792.
82. Hamler, R. L., Zhu, K., Buchanan, N. S., Kreunin, P. et al., A two-dimensional liquid-phase separation method coupled with mass spectrometry for proteomic studies of breast cancer and biomarker identification. Proteomics 2004, 4, 562-577.
83. Pankov, R., Umezawa, A., Maki, R., Der, C. J. et al., Oncogene activation of human keratin 18 transcription via the Ras signal transduction pathway. Proc. Natl. Acad. Sci. USA 1994, 91, 873-877.
84. Somiari, R. I., Sullivan, A., Russell, S., Somiari, S. et al., High-throughput proteomic analysis of human infiltrating ductal carcinoma of the breast. Proteomics 2003, 3, 1863-1873.
85. Franzen, B., Linder, S., Alaiya, A. A., Eriksson, E. et al., Analysis of polypeptide expression in benign and malignant human breast lesions: Down-regulation of cytokeratins. Br. J. Cancer 1996, 74, 1632-1638.
86. Czerwenka, K. F., Manavi, M., Hosmann, J., Jelincic, D. et al., Comparative analysis of two-dimensional protein patterns in malignant and normal human breast tissue. Cancer Detect. Prev. 2001, 25, 268-279.
87. Alaiya, A., Roblick, U., Egevad, L., Carlsson, A. et al., Polypeptide expression in prostate hyperplasia and prostate adenocarcinoma. Anal. Cell. Pathol. 2000, 21, 1-9.
88. Bergman, A. C., Benjamin, T., Alaiya, A., Waltham, M. et al., Identification of gel-separated tumor marker proteins by mass spectrometry. Electrophoresis 2000, 21, 679-686.
89. Iwaya, K., Ogawa, H., Mukai, Y., Iwamatsu, A., Mukai, K., Ubiquitin-immunoreactive degradation products of cytokeratin 8/18 correlate with aggressive breast cancer. Cancer Sci. 2003, 94, 864-870.
90. Turashvili, G., Bouchal, J., Burkadze, G., Kolar, Z., Mammary gland development and cancer. Cesk. Patol. 2005, 41, 94-101.
91. Zhang, D. H., Tai, L. K., Wong, L. L., Sethi, S. K., Koay, E. S., Proteomics of breast cancer: Enhanced expression of cytokeratin19 in human epidermal growth factor receptor type 2 positive breast tumors. Proteomics 2005, 5, 1797-1805.
92. Brown, L. M., Helmke, S. M., Hunsucker, S. W., Netea-Maier, R. T. et al., Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue. Mol. Carcinog. 2006, 45, 613-626.
93. Obermaier, C., Jankowski, V., Schmutzler, C., Bauer, J. et al., Free-flow isoelectric focusing of proteins remaining in cell fragments following sonication of thyroid carcinoma cells. Electrophoresis 2005, 26, 2109-2116.
94. Schonberger, J., Bauer, J., Spruss, T., Weber, G. et al., Establishment and characterization of the follicular thyroid carcinoma cell line ML-1. J. Mol. Med. 2000, 78, 102-110.
95. Bae, S. M., Lee, C. H., Cho, Y. L., Nam, K. H. et al., Two-dimensional gel analysis of protein expression profile in squamous cervical cancer patients. Gynecol. Oncol. 2005, 99, 26-35.
96. Hellman, K., Alaiya, A. A., Schedvins, K., Steinberg, W. et al., Protein expression patterns in primary carcinoma of the vagina. Br. J. Cancer 2004, 91, 319--326.
97. Alaiya, A. A., Oppermann, M., Langridge, J., Roblick, U. et al., Identification of proteins in human prostate tumor material by two-dimensional gel electrophoresis and mass spectrometry. Cell Mol. Life Sci. 2001, 58, 307-311.
98. Kellner, R., Lichtenfels, R., Atkins, D., Bukur, J. et al., Targeting of tumor associated antigens in renal cell carcinoma using proteome-based analysis and their clinical significance. Proteomics 2002, 2, 1743-1751.
99. Ostergaard, M., Rasmussen, H. H., Nielsen, H. V., Vorum, H. et al., Proteome profiling of bladder squamous cell carcinomas: Identification of markers that define their degree of differentiation. Cancer Res. 1997, 57, 4111-4117.
100. Kim, H. J., Sohng, I., Hwang, C. H., Park, J. Y., Cytokeratin-20 and seminal vesicle secretory protein VI as possible marker proteins in urinary bladder preneoplastic lesions induced by N-butyl-N-(4-hydroxybutyl) nitrosamine. Int. J. Urol. 2006, 13, 142-147.
101. Konety, B. R., Molecular markers in bladder cancer: A critical appraisal. Urol. Oncol. 2006, 24, 326-337.
102. Leu, A. T., Chiu, J. F., The possible role of cytokeratin 8 in cadmium-induced adaptation and carcinogenesis. Cancer Res. 2007, 67, 2107-2113.
103. Jiang, D., Ying, W., Lu, Y., Wan, J. et al., Identification of metastasis-associated proteins by proteomic analysis and functional exploration of interleukin-18 in metastasis. Proteomics 2003, 3, 724-737.
104. Schaafsma, H. E., Ramaekers, F. C., van Muijen, G. N., Robben, H. et al., Cytokeratin expression patterns in metastatic transitional cell carcinoma of the urinary tract. An immunohistochemical study comparing local tumor and autologous metastases. Am. J. Pathol. 1991, 139, 1389-1400.
105. Chu, Y. W., Yang, P. C., Yang, S. C., Shyu, Y. C. et al., Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line. Am. J. Respir. Cell. Mol. Biol. 1997, 17, 353-360.
106. Takikawa, M., Akiyama, Y., Maruyama, K., Suzuki, A. et al., Proteomic analysis of a highly metastatic gastric cancer cell line using two-dimensional differential gel electrophoresis. Oncol. Rep. 2006, 16, 705-711.
107. Ding, S. J., Li, Y., Tan, Y. X., Jiang, M. R. et al., From proteomic analysis to clinical significance: Overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis. Mol. Cell. Proteomics 2004, 3, 73-81.
108. Li, Y., Tang, Z. Y., Tian, B., Ye, S. L. et al., Serum CYFRA 21-1 level reflects hepatocellular carcinoma metastasis: Study in nude mice model and clinical patients. J. Cancer Res. Clin. Oncol. 2006, 132, 515-520.
109. Wu, F., Fujita, J., Murota, M., Li, J. Q. et al., CYFRA 21-1 is released in TNF-alpha-induced apoptosis in the hepatocellular carcinoma cell line HuH-7. Int. J. Oncol. 2002, 21, 441-445.
110. Su, Q., Fu, Y., Liu, Y. F., Zhang, W. et al., Laminin induces the expression of cytokeratin 19 in hepatocellular carcinoma cells growing in culture. World J. Gastroenterol. 2003, 9, 921-929.
111. Li, Y., Tang, Z. Y., Tian, B., Qin, L. X. et al., Study on the relationship between serum cytokeratin 19 level in hepatocellular carcinoma patients and the clinico-pathologic characteristics. Zhonghua Gan Zang Bing Za Zhi 2004, 12, 341-342.
112. Stasiak, P. C., Purkis, P. E., Leigh, I. M., Lane, E. B., Keratin 19: Predicted amino acid sequence and broad tissue distribution suggest it evolved from keratinocyte keratins. J. Invest. Dermatol. 1989, 92, 707-716.
113. Willipinski-Stapelfeldt, B., Riethdorf, S., Assmann, V., Woelfle, U. et al., Changes in cytoskeletal protein composition indicative of an epithelial-masenchymal transition in human micrometastatic and primary breast carcinoma cells. Clin. Cancer Res. 2005, 11, 8006-8014.
114. Celis, J. E., Celis, P., Ostergaard, M., Basse, B. et al., Proteomics and immunohistochemistry define some of the steps involved in the squamous differentiation of the bladder transitional epithelium: A novel strategy for identifying metaplastic lesions. Cancer Res. 1999, 59, 3003-3009.
115. Stuhler, K., Koper, K., Pfeiffer, K., Tagariello, A. et al., Differential proteome analysis of colon carcinoma cell line SW480 after reconstitution of the tumour suppressor Smad4. Anal. Bioanal. Chem. 2006, 386, 1603-1612.
116. Fu, Z., Fenselau, C., Proteomic evidence for roles for nucleolin and polyADP-ribosyl transferase in drug resistance. J. Proteome Res. 2005, 4, 1583-1591.
117. Monge, M., Vilaseca, M., Soto-Cerrato, V., Montaner, B. et al., Proteomic analysis of prodigiosin-induced apoptosis in a breast cancer mitoxantrone-resistant (MCF-7 MR) cell line. Invest. New Drugs 2007, 25, 21-29.
118. Chuthapisith, S., Layfield, R., Kerr, I. D., Hughes, C., Eremin, O., Proteomic profiling of MCF-7 breast cancer cells with chemoresistance to different types of anti-cancer drugs. Int. J. Oncol. 2007, 30, 1545-1551.
119. Liu, Y., Liu, H., Han, B., Zhang, J. T., Identification of 14-33sigma as a contributor to drug resistance in human breast cancer cells using functional proteomic analysis. Cancer Res. 2006, 66, 3248-3255.
120. Qin, H., Liu, T., Yang, J. L., Huang, X. et al., Screening proteins related to retinoic acid resistance by proteomic analysis. Zhonghua Yi Xue Za Zhi 2007, 87, 520-525.
121. Le Moguen, K., Lincet, H., Deslandes, E., Hubert-Roux, M. et al., Comparative proteomic analysis of cisplatin sensitive IGROV1 ovarian carcinoma cell line and its resistant counterpart GROVI-R10. Proteomics 2006, 6, 5183-5192.
122. Bauman, P. A., Dalton, W. S., Anderson, J. M., Cress, A. E., Expression of cytokeratin confers multiple drug resistance. Proc. Natl. Acad. Sci. USA 1994, 91, 5311-5314.
123. Ollero, M., Brouillard, F., Edelman, A., Cystic fibrosis enters the proteomics scene: New answers to old questions. Proteomics 2006, 6, 4084-4099.
124. Davezac, N., Tondelier, D., Lipecka, J., Fanen, P. et al., Global proteomic approach unmasks involvement of keratins 8 and 18 in the delivery of cystic fibrosis transmembrane conductance regulator (CFTR)/ deltaFS08-CFTR to the plasma membrane. Proteomics 2004, 4, 3833-3844.
125. Toivola, D. M., Ku, N. O., Resurreccion, E. Z., Nelson, D. R. et al., Keratin 8 and 18 hyperphosphorylation is a marker of progression of human liver disease. Hepatology 2004, 40, 459-466.
126. Janig, E., Stumptner, C., Fuchsbichler, A., Denk, H., Zatloukal, K., Interaction of stress proteins with misfolded keratins. Eur. J. Cell. Biol. 2005, 84, 329-339.
127. Gonsebatt, M. E., Del Razo, L. M., Cerbon, M. A., Zuniga, O. et al., Arsenite induced oxidative damage in mouse liver is associated with increased cytokeratin 18 expression. Arch. Toxicol. 2007, 6, 6.
128. Yilmaz, Y., Dolar, E., Ulukaya, E., Akgoz, S. et al., Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis. World J. Gastroenterol. 2007, 13, 837-844.
129. Ku, N. O., Michie, S., Oshima, R. G., Omary, M. B., Chronic hepatitis, hepatocyte fragility, and increased soluble phosphoglycokeratins in transgenic mice expressing a keratin 18 conserved arginine mutant. J. Cell. Biol. 1995, 131, 1303-1314.
130. Pitz, S., Moll, R., Intermediate-filament expression in ocular tissue. Prog. Retin Eye Res. 2002, 21, 241-262.
131. Nielsen, K., Vorum, H., Fagerholm, P., Birkenkamp-Demtroder, K. et al., Proteome profiling of corneal epithelium and identification of marker proteins for keratoconus, a pilot study. Exp. Eye Res. 2006, 82, 201-209.
132. Funding, M., Vorum, H., Honore, B., Nexo, E., Ehlers, N., Proteomic analysis of aqueous humour from patients with acute corneal rejection. Acta Ophthalmol. Scand. 2005, 83, 31-39.
133. Alge, C. S., Suppmann, S., Priglinger, S. G., Neubauer, A. S. et al., Comparative proteome analysis of native differentiated and cultured dedifferentiated human RPE cells. Invest. Ophthalmol. Vis. Sci. 2003, 44, 3629-3641.
134. Hunt, R. C., Davis, A. A., Altered expression of keratin and vimentin in human retinal pigment epithelial cells in vivo and in vitro. J. Cell. Physiol. 1990, 145, 187-199.
135. Kang, S. M., Shin, M. J., Kim, J.H., Oh, J. W., Proteomic profiling of cellular proteins interacting with the hepatitis C virus core protein. Proteomics 2005, 5, 2227-2237.
136. Brasier, A. R., Spratt, H., Wu, Z., Boldogh, I. et al., Nuclear heat shock response and novel nuclear domain 10 reorganization in respiratory syncytial virus-infected a549 cells identified by high-resolution two-dimensional gel electrophoresis. J. Virol. 2004, 78, 11461-11476.
137. Baek, H. Y., Lim, J. W., Kim, H., Kim, J. M. et al., Oxidative-stress-related proteome changes in Helicobacter pylori-infected human gastric mucosa. Biochem. J. 2004, 379, 291-299.
138. Page, N. M., Woods, R. J., Gardiner, S. M., Lomthaisong, K. et al., Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia. Nature 2000, 405, 797-800.
139. Sawicki, G., Dakour, J., Morrish, D. W., Functional proteomics of neurokinin B in the placenta indicates a novel role in regulating cytotrophoblast antioxidant defences. Proteomics 2003, 3, 2044-2051.
140. Collard, C. D., Montalto, M. C., Reenstra, W. R., Buras, J. A., Stahl, G. L., Endothelial oxidative stress activates the lectin complement pathway: Role of cytokeratin 1. Am J. Pathol. 2001, 159, 1045-1054.
141. Hu, R., Jin, H., Zhou, S., Yang, P., Li, X., Proteomic analysis of hypoxia-induced responses in the syncytialization of human placental cell line BeWo. Placenta 2007, 28, 399-407.
142. Baraniuk, J. N., Casado, B., Maibach, H., Clauw, D. J. et al., A Chronic Fatigue Syndrome - related proteome in human cerebrospinal fluid. BMC Neurol. 2005, 5, 22.
143. Wang, Y. N., Chang, W. C., Induction of disease-associated keratin 16 gene expression by epidermal growth factor is regulated through cooperation of transcription factors Spl and c-Jun. J. Biol. Chem. 2003, 278, 45848-45857.
144. Stasyk, T., Schiefermeier, N., Skvortsov, S., Zwierzina, H. et al., Identification of endosomal epidermal growth factor receptor signaling targets by functional organelle proteomics. Mol. Cell. Proteomics 2007, 6, 908-922.
145. Blagoev, B., Kratchmarova, I., Ong, S. E., Nielsen, M. et al., A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling. Nat Biotechnol. 2003, 21, 315-318.
146. Stasyk, T., Morandell, S., Bakry, R., Feuerstein, I. et al., Quantitative detection of phosphoproteins by combination of two-dimensional difference gel electrophoresis and phosphospecific fluorescent staining. Electrophoresis 2005, 26, 2850-2854.
147. Vandermoere, F., El Yazidi-Belkoura, I., Demont, Y., Slomianny, C. et al., Proteomics exploration reveals that actin is a signaling target of the kinase Akt. Mol. Cell. Proteomics 2007, 6, 114-124.
148. Malard, V., Prat, O., Darrouzet, E., Berenguer, F. et al., Proteomic analysis of the response of human lung cells to uranium. Proteomics 2005, 5, 4568-4580.
149. de Graauw, M., Le Devedec, S., Tijdens, I., Smeets, M. B. et al., Proteomic analysis of alternative protein tyrosine phosphorylation in 1,2-dichlorovinyl-cysteine-induced cytotoxicity in primary cultured rat renal proximal tubular cells. J. Pharmacol. Exp. Ther. 2007, 322, 89-100.
150. Son, W. K., Lee, D. Y., Lee, S. H., Joo, W. A., Kim, C. W., Analysis of proteins expressed in rat plasma exposed to dioxin using 2-dimensional gel electrophoresis. Proteomics 2003, 3, 2393-2401.
151. Svasti, J., Srisomsap, C., Subhasitanont, P., Keeratichamroen, S. et al., Proteomic profiling of cholangiocarcinoma cell line treated with pomiferin from Derris malaccensis. Proteomics 2005, 5, 4504-4509.
152. Tao, G. Z., Zhou, Q., Strnad, P., Salemi, M. R. et al., Human Ran cysteine 112 oxidation by pervanadate regulates its binding to keratins. J. Biol. Chem. 2005, 280, 12162-12167.
153. Omary, M. B., Ku, N. O., Toivola, D. M., Keratins: Guardians of the liver. Hepatology 2002, 35, 251-257.
154. Dihazi, H., Asif, A. R., Agarwal, N. K., Doncheva, Y., Muller, G. A., Proteomic analysis of cellular response to osmotic stress in thick ascending limb of Henle's loop (TALH) cells. Mol. Cell. Proteomics 2005, 4, 1445-1458.
155. Casanova, M. L., Bravo, A., Ramirez, A., Morreale de Escobar, G. et al., Exocrine pancreatic disorders in transsgenic mice expressing human keratin 8. J. Clin. Invest. 1999, 103, 1587-1595.
156. Jang, W. G., Kim, H. S., Park, K. G., Park, Y. B. et al., Analysis of proteome and transcriptome of tumor necrosis factor alpha stimulated vascular smooth muscle cells with or without alpha lipoic acid. Proteomics 2004, 4, 3383-3393.
157. Avram, D., Romijn, E. P., Pap, E. H., Heck, A. J., Wirtz, K. W., Identification of proteins in activated human neutrophils susceptible to tyrosyl radical attack. A proteomic study using a tyrosylating fluorophore. Proteomics 2004, 4, 2397-2407.
158. Casado, B., Pannell, L. K., Viglio, S., ladarola, P., Baraniuk, J. N., Analysis of the sinusitis nasal lavage fluid proteome using capillary liquid chromatography interaced to electrospray ionization-quadrupole time of flight- tandem mass spectrometry. Electrophoresis 2004, 25, 1386-1393.
159. Ahmed, M., Bergsten, P., Glucose-induced changes of multiple mouse islet proteins analysed by two-dimensional gel electrophoresis and mass spectrometry. Diabetologia 2005, 48, 477-485.
160. Hong, O. K., Suh, S. H., Kwon, H. S., Ko, S. H. et al., Proteomic analysis of differential protein expression in response to epidermal growth factor in neonatal porcine pancreatic cell monolayers. J. Cell. Biochem. 2005, 95, 769-781.
161. Hayman, M. W., Przyborski, S. A., Proteomic identification of biomarkers expressed by human pluripotent stem cells. Biochem. Biophys. Res. Commun. 2004, 316, 918-923.
162. Guo, X., Ying, W., Wan, J., Hu, Z. et al., Proteomic characterization of early-stage differentiation of mouse embryonic stem cells into neural cells induced by all-trans retinoic acid in vitro. Electrophoresis 2001, 22, 3067-3075.
163. Oh, J. E., Karlmark Raja, K., Shin, J. H., Pollak, A. et al., Cytoskeleton changes following differentiation of N1E-115 neuroblastoma cell line. Amino Acids 2006, 31, 289-298.
164. Tay, T. L., Lin, Q., Seow, T. K., Tan, K. H. et al., Proteomic analysis of protein profiles during early development of the zebrafish, Danio rerio. Proteomics 2006, 6, 3176-3188.
165. Morris, J. S., Davies, C. R., Griffiths, M. R., Page, M. J. et al., Proteomic analysis of mouse mammary terminal end buds identifies axonal growth cone proteins. Proteomics 2004, 4, 1802-1810.
166. Wawersik, M. J., Mazzalupo, S., Nguyen, D., Coulombe, P. A., Increased levels of keratin 16 alter epithelialization potential of mouse skin keratinocytes in vivo and ex vivo. Mol Biol. Cell 2001,
167. Kim, S., Wong, P., Coulombe, P. A., A keratin cytoskeletal protein regulates protein synthesis and epithelial cell growth. Nature 2006, 441, 362-365.
168. Lovestone, S., Guntert, A., Hye, A., Lynham, S. et al., Proteomics of Alzheimer's disease: Understanding mechanisms and seeking biomarkers. Expert Rev. Proteomics 2007, 4, 227-238.
169. Moll, R., Krepler, R., Franke, W. W., Complex cytokeratin polypeptide patterns observed in certain human carcinomas. Differentiation 1983, 23, 256-269.
170. Knosel, T., Emde, V., Schluns, K., Schlag, P. M. et al., Cytokeratin profiles identify diagnostic signatures in colorectal cancer using multiplex analysis of tissue microarrays. Cell Oncol. 2006, 28, 167-175.
171. Chasan, B., Geisse, N. A., Pedatella, K., Wooster, D. G. et al., Evidence for direct interaction between actin and the cystic fibrosis transmembrane conductance regulator. Eur. Biophys. J. 2002, 30, 617-624.
172. Haggie, P. M., Kim, J. K., Lukacs, G. L., Verkman, A. S., Tracking of quantum dot-labeled CFTR shows near immobilization by C-terminal PDZ interactions. Mol. Biol. Cell 2006, 17, 4937-4945.
173. Thelin, W. R., Chen, Y., Gentzsch, M., Kreda, S. M. et al., Direct interaction with filamins modulates the stability and plasma membrane expression of CFTR. J. Clin. Invest. 2007, 117, 364-374.
174. Izawa, I., Nishizawa, M., Ohtakara, K., Ohtsuka, K. et al., Identification of Mrj, a DnaJ/Hsp40 family protein, as a keratin 8/18 filament regulatory protein. J. Biol. Chem. 2000, 275, 34521-34527.
175. Lipecka, J., Norez, C., Bensalem, N., Baudouin-Legros, M. et al., Rescue of DeltaF508-CFTR (cystic fibrosis transmembrane conductance regulator) by curcumin: Involvement of the keratin 18 network. J. Pharmacol. Exp. Ther. 2006, 317, 500-505.
176. Moll, R., Dhouailly, D., Sun, T. T., Expression of keratin 5 as a distinctive feature of epithelial and biphasic mesotheliomas. An immunohistochemical study using monoclonal antibody AE14. Virchows Arch. B Cell. Pathol. Incl. Mol. Pathol. 1989, 58, 129-145.
177. Nikitakis, N. G., Tosios, K. I., Papanikolaou, V. S., Rivera, H. et al., Immunohistochemical expression of cytokeratins 7 and 20 in malignant salivary gland tumors. Mod. Pathol. 2004, 17, 407-415.
178. Takahashi, K., Paladini, R. D., Coulombe, P. A., Cloning and characterization of multiple human genes and cDNAs encoding highly related type II keratin 6 isoforms. J. Biol. Chem. 1995, 270, 18581-18592.
179. Sprecher, E., Itin, P., Whittock, N. V., McGrath, J. A. et al., Refined mapping of Naegeli-Franceschetti- Jadassohn syndrome to a 6 cM interval on chromosome 17q11.2-q21 and investigation of candidate genes. J. Invest. Dermatol. 2002, 119, 692-698.
180. Turhani, D., Krapfenbauer, K., Thurnher, D., Langen, H., Fountoulakis, M., Identification of differentially expressed, tumor-associated proteins in oral squamous cell carcinoma by proteomic analysis. Electrophoresis 2006, 27, 1417-1423.